ADGRE5 Gene - GeneCards | AGRE5 Protein | AGRE5 Antibody
2024年12月24日 · ADGRE5 (Adhesion G Protein-Coupled Receptor E5) is a Protein Coding gene. Diseases associated with ADGRE5 include Thyroid Cancer and Vibratory Urticaria . …
Comprehensive analysis of ADGRE5 gene in human tumors: …
2024年3月30日 · Based on ssGSEA, we explored the correlation of ADGRE5 with 28 immune cells in the UVM and found that ADGRE5 was significantly positively correlated with aDC, …
G Protein-Coupling of Adhesion GPCRs ADGRE2/EMR2 and ADGRE5 …
2020年1月22日 · The CD97 ‘full length’ clone (ADGRE5; Entrez gene ID: 976) was the splice variant encoding the signal sequence (MGGRV to GAETQ), EGF modules 1 (DSRGC to …
Here, we show that CD97 (ADGRE5) is the most promising aGPCR target in GBM, by virtue of its de novo expression compared to healthy brain tissue. CD97 knockdown or knockout …
The expression profile and tumorigenic mechanisms of CD97 (ADGRE5…
2023年11月28日 · Here, we show that CD97 (ADGRE5) is the most promising aGPCR target in GBM, by virtue of its de novo expression compared to healthy brain tissue. CD97 knockdown …
Identification of ADGRE5 as discriminating MYC target between …
2019年4月5日 · Our study describes a diverse genome-wide MYC-DNA binding pattern in BL and DLBCL cell lines with and without MYC translocations. Furthermore, we identified ADREG5 as …
粘附 G 蛋白偶联受体 E5（ADGRE5）基因 | MCE
该基因编码粘附 G 蛋白偶联受体的 EGF-TM7 亚家族成员，该受体介导细胞间相互作用。 这些蛋白质通过自催化蛋白水解被切割成大的细胞外亚基和七跨膜亚基，它们作为受体复合物结合在 …
Comprehensive analysis of ADGRE5 gene in human tumors
2024年3月7日 · Higher ADGRE5 levels were associated with worse prognosis in adrenocortical carcinoma, low grade glioma of the brain (LGG), lung squamous cell carcinoma, liver …
ADGRE5- 信号通路|蛋白抗体-华美生物
ADGRE5通过激活Wnt/β-catenin、PI3K/AKT等通路，与结直肠癌、胰腺癌等实体瘤的侵袭转移密切相关，其过表达可促进肿瘤血管生成和免疫逃逸。 在动脉粥样硬化领域，ADGRE5通过与 …
Adhesion GPCRs in immunology - ScienceDirect
2016年8月15日 · ADGRE5-expressing peripheral myeloid cells specifically adhere to CD90 + activated human dermal endothelial cells. Moreover, ADGRE5 + myeloid cells co-localise with …